Antiseizure medications are the primary treatment for epilepsy, and most people who take them achieve meaningful seizure control. These drugs work through a variety of mechanisms in the brain, from calming overactive nerve cells to modifying how chemical signals pass between them. But the landscape is far more complex than “take a pill, stop the seizures.” Roughly a third of people with epilepsy continue to have seizures despite trying multiple medications, and the drugs themselves carry side effects that range from mild drowsiness to serious risks during pregnancy.
How Antiseizure Medications Work
There is no single “antiseizure mechanism.” The brain can generate seizures in many ways, so the drugs that prevent them target different pieces of the electrical and chemical machinery. The largest and oldest group works by blocking sodium channels, the tiny gates on nerve cells that open to let electrical signals fire. When these channels are blocked, neurons become less likely to fire in the rapid, synchronized bursts that constitute a seizure. Drugs in this category include carbamazepine, oxcarbazepine, lamotrigine, lacosamide, eslicarbazepine, and phenytoin, and a Chinese expert panel recently reaffirmed consensus recommendations for several of these specifically in focal epilepsy.1PubMed. Sodium channel blockers for the treatment of focal epilepsy: A Chinese expert consensus
A different class targets calcium channels. Absence seizures, the brief “blank stare” episodes most common in children, are driven partly by a specific type of calcium channel called T-type channels. Ethosuximide, the go-to drug for childhood absence epilepsy, works largely by blocking these channels, a role confirmed by evidence from genetic animal models and laboratory expression systems.2PubMed Central. Block of T-Type Ca(2+) Channels Is an Important Action of Succinimide Antiabsence Drugs
Then there are drugs that do not fit neatly into either camp. Levetiracetam, one of the most widely prescribed antiseizure medications worldwide, binds to a protein on the surface of synaptic vesicles called SV2A. Researchers demonstrated that brain tissue from mice lacking SV2A does not bind to levetiracetam at all, and that a compound’s affinity for SV2A closely predicts its ability to prevent seizures in animal models.3PubMed Central. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam In practical terms, levetiracetam seems to dampen the release of chemical signals between neurons rather than blocking electrical firing directly.
Other mechanisms include enhancing the activity of GABA (the brain’s main inhibitory chemical messenger) and blocking glutamate receptors (the main excitatory messenger). Some drugs, like valproic acid and topiramate, appear to work through several mechanisms at once, which may explain both their broad effectiveness and their wider side-effect profiles.
When a Seizure Will Not Stop
The medications described above are taken daily to prevent seizures. But when a seizure is actively happening and will not stop on its own, a different class of drugs takes over: benzodiazepines. Status epilepticus, a seizure lasting longer than five minutes or repeated seizures without recovery between them, is a medical emergency. Benzodiazepines like diazepam, lorazepam, and midazolam are the first-line treatments because they act within minutes, boosting GABA signaling to quiet the electrical storm.4PubMed. Medical management of status epilepticus: Emergency room to intensive care unit
Midazolam has become the preferred choice in prehospital settings because it can be given through the cheek, sprayed into the nose, or injected into a muscle, none of which require an IV line. When IV access is available, lorazepam or diazepam are both suitable. The speed of getting the drug into the person matters more than which specific benzodiazepine is chosen.5PubMed. Prehospital rescue treatment of cluster epileptic seizures and status epilepticus If benzodiazepines fail to break the seizure, hospital teams escalate to IV antiseizure drugs like fosphenytoin, valproic acid, or levetiracetam, and in refractory cases, to general anesthesia.
Side Effects Worth Knowing About
All antiseizure medications can cause side effects, but the type and severity vary dramatically by drug. The most common complaints across the board are drowsiness, dizziness, and problems with coordination, especially when starting a new medication or increasing the dose. These often ease after a few weeks as the body adjusts.
Cognitive effects deserve special attention because they affect daily life in ways that are easy to undercount. Antiseizure drugs can dull attention, slow processing speed, and impair memory and language fluency.6PubMed Central. Cognitive effects of antiepileptic drugs These effects vary widely between drug classes, doses, and individual susceptibility.7PubMed. Cognitive Side Effects of Antiseizure Medications in Adults with Epilepsy: An Update with a Focus on New Therapeutic Agents Topiramate is particularly notorious for what patients sometimes call “brain fog,” while levetiracetam and lamotrigine tend to be considered more cognitively gentle, though individual responses differ.
Some risks are rare but severe. Certain antiseizure medications can trigger dangerous skin reactions like Stevens-Johnson syndrome, where the skin and mucous membranes blister and peel. Genetic testing has identified specific immune-system gene variants that raise this risk. In Asian populations, a meta-analysis found that carrying the HLA-B*1502 allele raised the odds of lamotrigine-induced Stevens-Johnson syndrome in Chinese populations, and HLA-A*2402 was a risk factor for both severe and milder skin reactions.8PubMed. Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis These skin reactions are unpredictable based on clinical factors alone, which is why genomic screening is increasingly recommended before starting certain drugs.9PubMed. HLA-associated antiepileptic drug-induced cutaneous adverse reactions
Pregnancy and Valproic Acid
Valproic acid stands apart from other antiseizure medications when it comes to pregnancy risk. It is a known human teratogen, meaning it causes birth defects. Exposure during pregnancy is linked to roughly a threefold increase in major anomalies, with spina bifida being the most characteristic. It is also associated with cardiac defects, craniofacial abnormalities, and limb defects, along with developmental problems in children, including reduced verbal intelligence and features of autism spectrum disorder.10PubMed. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
A large study comparing women who took valproic acid during the first trimester to those who took no antiseizure drugs found strikingly elevated risks for specific malformations. The risk of spina bifida was about 13 times higher, cleft palate about five times higher, and craniosynostosis (premature fusion of skull bones) about seven times higher.11PubMed. Valproic acid monotherapy in pregnancy and major congenital malformations Because of these findings, valproic acid is now avoided whenever possible in women of childbearing age, and regulators in many countries require prescribers to discuss contraception before starting it. Other antiseizure drugs carry lower pregnancy risks, though no medication is entirely without concern during pregnancy, and neurologists work with patients to find the safest option that still controls seizures.
Why Medications Fail for Some People
About 30 percent of people with epilepsy do not achieve seizure freedom despite trying two or more medications at adequate doses. This drug resistance is one of the hardest problems in epilepsy care, and researchers have proposed several explanations without settling on a single answer.
The transporter hypothesis suggests that the blood-brain barrier becomes harder for drugs to cross. Specifically, efflux transporters, proteins that actively pump substances back out of brain tissue, may be overexpressed in epileptic brain regions, reducing how much drug actually reaches the seizure focus.12PubMed. Cerebral expression of drug transporters in epilepsy The target hypothesis takes a different angle: it proposes that the brain structures these drugs act on, such as sodium channels or neurotransmitter receptors, change their shape or behavior as a result of repeated seizures, making the drugs less effective at binding to them.13PubMed Central. Drug-resistant epilepsy: Drug target hypothesis and beyond the receptors14Brain. Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Neither hypothesis fully explains drug resistance on its own, and researchers increasingly suspect that multiple mechanisms operate simultaneously in the same patient.15PubMed Central. Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers Other proposed factors include differences in how seizure networks are organized, genetic variation in drug metabolism, and the possibility that some forms of epilepsy are simply driven by pathways that no current drug adequately targets. For people with drug-resistant epilepsy, the conversation shifts toward surgery, neurostimulation devices, and dietary therapies.
Alternatives and Add-On Therapies
When medications alone are not enough, several non-drug treatments can be layered on top. The ketogenic diet, a very high-fat, low-carbohydrate eating pattern, has been used since the 1920s and remains an option for drug-resistant epilepsy, particularly in children.16PubMed Central. Ketogenic Diet and Epilepsy The diet forces the body to burn fat instead of glucose, producing ketone bodies that appear to have direct anti-seizure effects in the brain, though the exact mechanism is still being worked out.
Vagus nerve stimulation (VNS), a surgically implanted device that sends regular electrical pulses to the vagus nerve in the neck, is another well-established option. VNS does not replace medications but often works alongside them, and certain drug-device combinations appear more effective than others. A study analyzing VNS outcomes found that pairing the device with SV2A modulators like levetiracetam or brivaracetam yielded a responder rate of about 64 percent, while pairing it with slow sodium channel inhibitors like lacosamide or eslicarbazepine yielded about 62 percent. Both combinations significantly outperformed other drug-VNS pairings.17PubMed Central. Synergistic effects of vagus nerve stimulation and antiseizure medication Beyond seizure counts, these same combinations showed meaningful improvements in quality of life and depression scores at two years.18Epilepsy & Behavior. Favorable combinations of antiseizure medication with vagus nerve stimulation to improve health-related quality of life in patients with epilepsy
Responsive neurostimulation (RNS) is a newer device that monitors brain activity in real time and delivers targeted electrical pulses only when it detects the beginning of a seizure. Some pediatric patients now use VNS and RNS simultaneously, and early safety data have been reassuring: no device-device interactions were noted, and neither stimulator interfered with the other’s function.19Journal of Neurosurgery: Pediatrics. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for multifocal and generalized onset epilepsy in pediatric patients
When Genetics Changes the Playbook
One of the most striking advances in epilepsy treatment is the realization that the same drug can be a lifesaver for one genetic condition and harmful in another, even when both conditions involve the same family of proteins. Dravet syndrome, a severe childhood epilepsy caused by loss-of-function mutations in the SCN1A sodium channel gene, is a clear example. Sodium channel blockers like carbamazepine or phenytoin, which work by reducing sodium channel activity even further, can make seizures dramatically worse in these children.20Neurotherapeutics. Current Perspectives From Genetic Testing to Precision Medicine in Epilepsy
But flip the genetic script: in children with gain-of-function mutations in SCN2A or SCN8A, where the sodium channels are too active, sodium channel blockers become the main therapeutic strategy.21Neurotherapeutics. Current Perspectives From Genetic Testing to Precision Medicine in Epilepsy This is precision medicine at its sharpest, and it explains why genetic testing has become so central to treating severe childhood epilepsies. Dravet syndrome now has several recently approved therapies beyond traditional antiseizure drugs, including fenfluramine and cannabidiol, and is considered a model for how precise genetic diagnosis can guide treatment choices.22PubMed Central. Dravet Syndrome as an Example of Precision Medicine in Epilepsy Treatment can also be targeted in other genetic causes of infantile-onset epilepsy, including mutations in potassium channel genes, tuberous sclerosis, and certain inborn metabolic diseases.23PubMed. Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies
Treating Epilepsy in Older Adults
Epilepsy is actually most common at the extremes of life: in early childhood and in people over 65. In older adults, new-onset seizures are frequently caused by strokes, brain tumors, or neurodegenerative disease. Choosing the right medication in this age group is complicated by the body’s changing chemistry. Protein binding shifts, the liver and kidneys clear drugs more slowly, gut absorption can be altered, and older adults are often taking several other medications for conditions like heart disease or diabetes.24PubMed. Treatment of epilepsy in the elderly
Drug interactions are a major concern. Older antiseizure medications like phenytoin and carbamazepine are strong inducers of liver enzymes, meaning they speed up the metabolism of many other drugs, potentially making blood thinners, blood pressure medications, or chemotherapy agents less effective. Newer drugs like levetiracetam and lacosamide have fewer interactions, which is a significant advantage. Doses also generally need to be lower and titrated more slowly, because side effects like dizziness and sedation carry a higher risk of falls in older adults.
The Psychiatric Side of Things
The relationship between antiseizure medications and mental health runs in both directions. Some drugs have mood-stabilizing or anti-anxiety effects and are prescribed to people who do not even have epilepsy: valproic acid, carbamazepine, and lamotrigine are all established treatments for bipolar disorder, and pregabalin has recognized anxiolytic properties.25PubMed Central. Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points
On the other hand, several antiseizure drugs can provoke psychiatric symptoms. Levetiracetam, despite being well tolerated physically, is known for irritability and aggression in a subset of patients. Topiramate can worsen depression. Perampanel has been linked to aggressive behavior and even psychosis.26PubMed Central. Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points This matters because psychiatric conditions are already common in people with epilepsy, with some estimates suggesting prevalence up to 50 percent. People on multiple antiseizure medications and those with poor seizure control are at even higher risk of psychiatric comorbidities.27PubMed Central. Psychiatric implications of anti-seizure medications in epileptic population A good neurologist considers the whole picture when choosing a drug: if you already struggle with depression, levetiracetam might not be the first choice, even if it is otherwise an excellent seizure medication.
Stopping or Reducing Medication
After years of seizure freedom, many people understandably wonder whether they can stop taking their medication. Some can. But withdrawal needs to happen gradually, and the process carries real risk. A classic study of drug withdrawal found that rapid dose reductions caused a rebound effect: generalized seizures could spike during a brief period, or partial seizures could increase over a longer stretch. These increases in seizure frequency were tied to the change in dose itself rather than to how low the dose got, meaning they were largely confined to the period right after a reduction.28PubMed. Patterns of seizure activation after withdrawal of antiepileptic medication
This is why neurologists taper medications slowly over weeks to months rather than stopping abruptly. Even with a careful taper, seizure recurrence happens in a meaningful percentage of people, and the decision to try withdrawal depends on factors like the underlying cause of epilepsy, how long the person has been seizure-free, EEG findings, and whether the person drives or operates machinery where a breakthrough seizure could be dangerous.
Monitoring Drug Levels
For some antiseizure medications, blood level monitoring (therapeutic drug monitoring, or TDM) can be genuinely useful. Phenytoin is the classic case: it has unusual pharmacokinetics where small dose increases can produce disproportionately large jumps in blood levels, making toxicity hard to predict clinically. For phenytoin and other drugs with complex metabolism, checking blood levels helps guide dosing.29PubMed Central. Clinical utility of therapeutic drug monitoring of antiepileptic drugs: Systematic review
For many newer drugs, the picture is less clear. Blood levels are a snapshot, not the whole story, and they need to be interpreted alongside what the patient actually reports about seizure control and side effects. The future direction points toward combining blood-level monitoring with genetic panels, so that drug choice, dosing, and monitoring are all tailored to the individual patient’s biology.30PubMed. Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring
How Antiseizure Drugs Were Found
The history of antiseizure medication development is surprisingly haphazard. Phenobarbital, one of the oldest and still most widely used antiseizure drugs globally, was discovered by accident in 1912 when it was being used as a sedative and a physician noticed it stopped seizures. Valproic acid was similarly serendipitous: it was being used as a laboratory solvent to dissolve other compounds being tested for anticonvulsant activity, and researchers noticed that all the compounds dissolved in it seemed to work. It turned out the solvent itself was the active ingredient.31PubMed Central. Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence
The field became more systematic over the twentieth century, developing standardized animal models to screen candidate drugs. More recently, artificial intelligence has entered the drug-discovery pipeline, analyzing molecular structures and predicting which compounds are likely to have anticonvulsant activity before they ever reach a laboratory animal. Whether AI-assisted drug discovery will produce genuinely novel mechanisms or simply optimize existing ones remains to be seen, but the era of finding antiseizure drugs by accident is largely over.
Biomarkers and What They Could Change
One of the frustrating realities of epilepsy treatment is that it is largely reactive: you try a drug, wait to see if seizures stop, and switch if they do not. Researchers are working to change this by identifying biomarkers that could predict which patients will respond to which treatments, who is likely to develop drug resistance, and even who is at risk of developing epilepsy after a brain injury before the first seizure ever occurs. Candidate biomarkers span a wide range, from molecules in blood and cerebrospinal fluid to patterns on EEGs and brain imaging.32PubMed Central. Epilepsy biomarkers – Toward etiology and pathology specificity None have entered routine clinical use yet, but the goal is a future where treatment selection is guided by biology rather than trial and error.